Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine’s Biological Activity

Journal of Medicinal Chemistry
2020.0

Abstract

Innovative discovery strategies are essential to address the ongoing opioid epidemic in the United States. Misuse of prescription and illegal opioids (e.g., morphine, heroin) has led to major problems with addiction and overdose. We used vincamine, an indole alkaloid, as a synthetic starting point for dramatic structural alterations of its complex, fused ring system to synthesize 80 diverse compounds with intricate molecular architectures. A select series of vincamine-derived compounds were screened for both agonistic and antagonistic activities against a panel of 168 G protein-coupled receptor (GPCR) drug targets. Although vincamine was without an effect, the novel compound 4 (V2a) demonstrated antagonistic activities against hypocretin (orexin) receptor 2. When advanced to animal studies, 4 (V2a) significantly prevented acute morphine-conditioned place preference (CPP) and stress-induced reinstatement of extinguished morphine-CPP in mouse models of opioid reward and relapse. These results demonstrate that the ring distortion of vincamine offers a promising way to explore new chemical space of relevance to opioid addiction.

Knowledge Graph

Similar Paper

Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine’s Biological Activity
Journal of Medicinal Chemistry 2020.0
Synthesis and characterizations of novel quinoline derivatives having mixed ligand activities at the κ and μ receptors: Potential therapeutic efficacy against morphine dependence
Bioorganic & Medicinal Chemistry 2009.0
Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists
Scientific Reports 2020.0
Yohimbine as a Starting Point to Access Diverse Natural Product-Like Agents with Re-programmed Activities against Cancer-Relevant GPCR Targets
Bioorganic & Medicinal Chemistry 2020.0
Opioid Receptor Modulators with a Cinnamyl Group
Journal of Medicinal Chemistry 2017.0
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability
Journal of Medicinal Chemistry 2016.0
The Power of Visual Imagery in Drug Design. Isopavines as a New Class of Morphinomimetics and Their Human Opioid Receptor Binding Activity
Journal of Medicinal Chemistry 2003.0
Synthesis and Pharmacology of a Novel κ Opioid Receptor (KOR) Agonist with a 1,3,5-Trioxazatriquinane Skeleton
ACS Medicinal Chemistry Letters 2014.0
Synthesis of a novel 6,14-epoxymorphinan derivative and its pharmacology
Bioorganic & Medicinal Chemistry Letters 2008.0
Synthesis and biochemical evaluation of 17-N-beta-aminoalkyl-4,5α-epoxynormorphinans
Scientific Reports 2023.0